Global Hemophilia Gene Therapy Market Size, Status and Forecast 2022

Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and spontaneous bleeding episodes that often lead to joint disease such as arthritis. The most frequent forms of hemophilia affect males.

Market Analysis and Insights: Global Hemophilia Gene Therapy Market

In 2021, the global Hemophilia Gene Therapy market size will be US$ million and it is expected to reach US$ million by the end of 2027, with a CAGR of % during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemophilia Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemophilia Gene Therapy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemophilia Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemophilia Gene Therapy market.

Global Hemophilia Gene Therapy Scope and Market Size

Hemophilia Gene Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemophilia Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Hemophilia A

Hemophilia B

Hemophilia A Gene Therapy

Hemophilia B Gene Therapy

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Spark Therapeutics

Ultragenyx

Shire PLC

Sangamo Therapeutics

Bioverativ

BioMarin

uniQure

Freeline Therapeutics

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Hemophilia A

1.2.3 Hemophilia B

1.3 Market by Application

1.3.1 Global Hemophilia Gene Therapy Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Hemophilia A Gene Therapy

1.3.3 Hemophilia B Gene Therapy

1.4 Study Objectives

1.5 Years Considered

2.1 Global Hemophilia Gene Therapy Market Perspective (2016-2027)

2.2 Hemophilia Gene Therapy Growth Trends by Regions

2.2.1 Hemophilia Gene Therapy Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Hemophilia Gene Therapy Historic Market Share by Regions (2016-2021)

2.2.3 Hemophilia Gene Therapy Forecasted Market Size by Regions (2022-2027)

2.3 Hemophilia Gene Therapy Industry Dynamic

2.3.1 Hemophilia Gene Therapy Market Trends

2.3.2 Hemophilia Gene Therapy Market Drivers

2.3.3 Hemophilia Gene Therapy Market Challenges

2.3.4 Hemophilia Gene Therapy Market Restraints

3.1 Global Top Hemophilia Gene Therapy Players by Revenue

3.1.1 Global Top Hemophilia Gene Therapy Players by Revenue (2016-2021)

3.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Players (2016-2021)

3.2 Global Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Hemophilia Gene Therapy Revenue

3.4 Global Hemophilia Gene Therapy Market Concentration Ratio

3.4.1 Global Hemophilia Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hemophilia Gene Therapy Revenue in 2020

3.5 Hemophilia Gene Therapy Key Players Head office and Area Served

3.6 Key Players Hemophilia Gene Therapy Product Solution and Service

3.7 Date of Enter into Hemophilia Gene Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Hemophilia Gene Therapy Historic Market Size by Type (2016-2021)

4.2 Global Hemophilia Gene Therapy Forecasted Market Size by Type (2022-2027)

5.1 Global Hemophilia Gene Therapy Historic Market Size by Application (2016-2021)

5.2 Global Hemophilia Gene Therapy Forecasted Market Size by Application (2022-2027)

6.1 North America Hemophilia Gene Therapy Market Size (2016-2027)

6.2 North America Hemophilia Gene Therapy Market Size by Type

6.2.1 North America Hemophilia Gene Therapy Market Size by Type (2016-2021)

6.2.2 North America Hemophilia Gene Therapy Market Size by Type (2022-2027)

6.2.3 North America Hemophilia Gene Therapy Market Size by Type (2016-2027)

6.3 North America Hemophilia Gene Therapy Market Size by Application

6.3.1 North America Hemophilia Gene Therapy Market Size by Application (2016-2021)

6.3.2 North America Hemophilia Gene Therapy Market Size by Application (2022-2027)

6.3.3 North America Hemophilia Gene Therapy Market Size by Application (2016-2027)

6.4 North America Hemophilia Gene Therapy Market Size by Country

6.4.1 North America Hemophilia Gene Therapy Market Size by Country (2016-2021)

6.4.2 North America Hemophilia Gene Therapy Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7.1 Europe Hemophilia Gene Therapy Market Size (2016-2027)

7.2 Europe Hemophilia Gene Therapy Market Size by Type

7.2.1 Europe Hemophilia Gene Therapy Market Size by Type (2016-2021)

7.2.2 Europe Hemophilia Gene Therapy Market Size by Type (2022-2027)

7.2.3 Europe Hemophilia Gene Therapy Market Size by Type (2016-2027)

7.3 Europe Hemophilia Gene Therapy Market Size by Application

7.3.1 Europe Hemophilia Gene Therapy Market Size by Application (2016-2021)

7.3.2 Europe Hemophilia Gene Therapy Market Size by Application (2022-2027)

7.3.3 Europe Hemophilia Gene Therapy Market Size by Application (2016-2027)

7.4 Europe Hemophilia Gene Therapy Market Size by Country

7.4.1 Europe Hemophilia Gene Therapy Market Size by Country (2016-2021)

7.4.2 Europe Hemophilia Gene Therapy Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8.1 Asia-Pacific Hemophilia Gene Therapy Market Size (2016-2027)

8.2 Asia-Pacific Hemophilia Gene Therapy Market Size by Type

8.2.1 Asia-Pacific Hemophilia Gene Therapy Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Hemophilia Gene Therapy Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Hemophilia Gene Therapy Market Size by Type (2016-2027)

8.3 Asia-Pacific Hemophilia Gene Therapy Market Size by Application

8.3.1 Asia-Pacific Hemophilia Gene Therapy Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Hemophilia Gene Therapy Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Hemophilia Gene Therapy Market Size by Application (2016-2027)

8.4 Asia-Pacific Hemophilia Gene Therapy Market Size by Region

8.4.1 Asia-Pacific Hemophilia Gene Therapy Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Hemophilia Gene Therapy Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Hemophilia Gene Therapy Market Size (2016-2027)

9.2 Latin America Hemophilia Gene Therapy Market Size by Type

9.2.1 Latin America Hemophilia Gene Therapy Market Size by Type (2016-2021)

9.2.2 Latin America Hemophilia Gene Therapy Market Size by Type (2022-2027)

9.2.3 Latin America Hemophilia Gene Therapy Market Size by Type (2016-2027)

9.3 Latin America Hemophilia Gene Therapy Market Size by Application

9.3.1 Latin America Hemophilia Gene Therapy Market Size by Application (2016-2021)

9.3.2 Latin America Hemophilia Gene Therapy Market Size by Application (2022-2027)

9.3.3 Latin America Hemophilia Gene Therapy Market Size by Application (2016-2027)

9.4 Latin America Hemophilia Gene Therapy Market Size by Country

9.4.1 Latin America Hemophilia Gene Therapy Market Size by Country (2016-2021)

9.4.2 Latin America Hemophilia Gene Therapy Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Hemophilia Gene Therapy Market Size (2016-2027)

10.2 Middle East & Africa Hemophilia Gene Therapy Market Size by Type

10.2.1 Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2016-2027)

10.3 Middle East & Africa Hemophilia Gene Therapy Market Size by Application

10.3.1 Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2016-2027)

10.4 Middle East & Africa Hemophilia Gene Therapy Market Size by Country

10.4.1 Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Spark Therapeutics

11.1.1 Spark Therapeutics Company Details

11.1.2 Spark Therapeutics Business Overview

11.1.3 Spark Therapeutics Hemophilia Gene Therapy Introduction

11.1.4 Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2016-2021)

11.1.5 Spark Therapeutics Recent Development

11.2 Ultragenyx

11.2.1 Ultragenyx Company Details

11.2.2 Ultragenyx Business Overview

11.2.3 Ultragenyx Hemophilia Gene Therapy Introduction

11.2.4 Ultragenyx Revenue in Hemophilia Gene Therapy Business (2016-2021)

11.2.5 Ultragenyx Recent Development

11.3 Shire PLC

11.3.1 Shire PLC Company Details

11.3.2 Shire PLC Business Overview

11.3.3 Shire PLC Hemophilia Gene Therapy Introduction

11.3.4 Shire PLC Revenue in Hemophilia Gene Therapy Business (2016-2021)

11.3.5 Shire PLC Recent Development

11.4 Sangamo Therapeutics

11.4.1 Sangamo Therapeutics Company Details

11.4.2 Sangamo Therapeutics Business Overview

11.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Introduction

11.4.4 Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2016-2021)

11.4.5 Sangamo Therapeutics Recent Development

11.5 Bioverativ

11.5.1 Bioverativ Company Details

11.5.2 Bioverativ Business Overview

11.5.3 Bioverativ Hemophilia Gene Therapy Introduction

11.5.4 Bioverativ Revenue in Hemophilia Gene Therapy Business (2016-2021)

11.5.5 Bioverativ Recent Development

11.6 BioMarin

11.6.1 BioMarin Company Details

11.6.2 BioMarin Business Overview

11.6.3 BioMarin Hemophilia Gene Therapy Introduction

11.6.4 BioMarin Revenue in Hemophilia Gene Therapy Business (2016-2021)

11.6.5 BioMarin Recent Development

11.7 uniQure

11.7.1 uniQure Company Details

11.7.2 uniQure Business Overview

11.7.3 uniQure Hemophilia Gene Therapy Introduction

11.7.4 uniQure Revenue in Hemophilia Gene Therapy Business (2016-2021)

11.7.5 uniQure Recent Development

11.8 Freeline Therapeutics

11.8.1 Freeline Therapeutics Company Details

11.8.2 Freeline Therapeutics Business Overview

11.8.3 Freeline Therapeutics Hemophilia Gene Therapy Introduction

11.8.4 Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2016-2021)

11.8.5 Freeline Therapeutics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Hemophilia Gene Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

    Table 2. Key Players of Hemophilia A

    Table 3. Key Players of Hemophilia B

    Table 4. Global Hemophilia Gene Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

    Table 5. Global Hemophilia Gene Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

    Table 6. Global Hemophilia Gene Therapy Market Size by Regions (2016-2021) & (US$ Million)

    Table 7. Global Hemophilia Gene Therapy Market Share by Regions (2016-2021)

    Table 8. Global Hemophilia Gene Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 9. Global Hemophilia Gene Therapy Market Share by Regions (2022-2027)

    Table 10. Hemophilia Gene Therapy Market Trends

    Table 11. Hemophilia Gene Therapy Market Drivers

    Table 12. Hemophilia Gene Therapy Market Challenges

    Table 13. Hemophilia Gene Therapy Market Restraints

    Table 14. Global Hemophilia Gene Therapy Revenue by Players (2016-2021) & (US$ Million)

    Table 15. Global Hemophilia Gene Therapy Market Share by Players (2016-2021)

    Table 16. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Gene Therapy as of 2020)

    Table 17. Ranking of Global Top Hemophilia Gene Therapy Companies by Revenue (US$ Million) in 2020

    Table 18. Global 5 Largest Players Market Share by Hemophilia Gene Therapy Revenue (CR5 and HHI) & (2016-2021)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Hemophilia Gene Therapy Product Solution and Service

    Table 21. Date of Enter into Hemophilia Gene Therapy Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Hemophilia Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 24. Global Hemophilia Gene Therapy Revenue Market Share by Type (2016-2021)

    Table 25. Global Hemophilia Gene Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)

    Table 26. Global Hemophilia Gene Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)

    Table 27. Global Hemophilia Gene Therapy Market Size Share by Application (2016-2021) & (US$ Million)

    Table 28. Global Hemophilia Gene Therapy Revenue Market Share by Application (2016-2021)

    Table 29. Global Hemophilia Gene Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)

    Table 30. Global Hemophilia Gene Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)

    Table 31. North America Hemophilia Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 32. North America Hemophilia Gene Therapy Market Size by Type (2022-2027) & (US$ Million)

    Table 33. North America Hemophilia Gene Therapy Market Size by Application (2016-2021) (US$ Million)

    Table 34. North America Hemophilia Gene Therapy Market Size by Application (2022-2027) & (US$ Million)

    Table 35. North America Hemophilia Gene Therapy Market Size by Country (2016-2021) & (US$ Million)

    Table 36. North America Hemophilia Gene Therapy Market Size by Country (2022-2027) & (US$ Million)

    Table 37. Europe Hemophilia Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 38. Europe Hemophilia Gene Therapy Market Size by Type (2022-2027) & (US$ Million)

    Table 39. Europe Hemophilia Gene Therapy Market Size by Application (2016-2021) (US$ Million)

    Table 40. Europe Hemophilia Gene Therapy Market Size by Application (2022-2027) & (US$ Million)

    Table 41. Europe Hemophilia Gene Therapy Market Size by Country (2016-2021) & (US$ Million)

    Table 42. Europe Hemophilia Gene Therapy Market Size by Country (2022-2027) & (US$ Million)

    Table 43. Asia-Pacific Hemophilia Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 44. Asia-Pacific Hemophilia Gene Therapy Market Size by Type (2022-2027) & (US$ Million)

    Table 45. Asia-Pacific Hemophilia Gene Therapy Market Size by Application (2016-2021) (US$ Million)

    Table 46. Asia-Pacific Hemophilia Gene Therapy Market Size by Application (2022-2027) & (US$ Million)

    Table 47. Asia-Pacific Hemophilia Gene Therapy Market Size by Region (2016-2021) & (US$ Million)

    Table 48. Asia-Pacific Hemophilia Gene Therapy Market Size by Region (2022-2027) & (US$ Million)

    Table 49. Latin America Hemophilia Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 50. Latin America Hemophilia Gene Therapy Market Size by Type (2022-2027) & (US$ Million)

    Table 51. Latin America Hemophilia Gene Therapy Market Size by Application (2016-2021) (US$ Million)

    Table 52. Latin America Hemophilia Gene Therapy Market Size by Application (2022-2027) & (US$ Million)

    Table 53. Latin America Hemophilia Gene Therapy Market Size by Country (2016-2021) & (US$ Million)

    Table 54. Latin America Hemophilia Gene Therapy Market Size by Country (2022-2027) & (US$ Million)

    Table 55. Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 56. Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2022-2027) & (US$ Million)

    Table 57. Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2016-2021) (US$ Million)

    Table 58. Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2022-2027) & (US$ Million)

    Table 59. Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2016-2021) & (US$ Million)

    Table 60. Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2022-2027) & (US$ Million)

    Table 61. Spark Therapeutics Company Details

    Table 62. Spark Therapeutics Business Overview

    Table 63. Spark Therapeutics Hemophilia Gene Therapy Product

    Table 64. Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2016-2021) & (US$ Million)

    Table 65. Spark Therapeutics Recent Development

    Table 66. Ultragenyx Company Details

    Table 67. Ultragenyx Business Overview

    Table 68. Ultragenyx Hemophilia Gene Therapy Product

    Table 69. Ultragenyx Revenue in Hemophilia Gene Therapy Business (2016-2021) & (US$ Million)

    Table 70. Ultragenyx Recent Development

    Table 71. Shire PLC Company Details

    Table 72. Shire PLC Business Overview

    Table 73. Shire PLC Hemophilia Gene Therapy Product

    Table 74. Shire PLC Revenue in Hemophilia Gene Therapy Business (2016-2021) & (US$ Million)

    Table 75. Shire PLC Recent Development

    Table 76. Sangamo Therapeutics Company Details

    Table 77. Sangamo Therapeutics Business Overview

    Table 78. Sangamo Therapeutics Hemophilia Gene Therapy Product

    Table 79. Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2016-2021) & (US$ Million)

    Table 80. Sangamo Therapeutics Recent Development

    Table 81. Bioverativ Company Details

    Table 82. Bioverativ Business Overview

    Table 83. Bioverativ Hemophilia Gene Therapy Product

    Table 84. Bioverativ Revenue in Hemophilia Gene Therapy Business (2016-2021) & (US$ Million)

    Table 85. Bioverativ Recent Development

    Table 86. BioMarin Company Details

    Table 87. BioMarin Business Overview

    Table 88. BioMarin Hemophilia Gene Therapy Product

    Table 89. BioMarin Revenue in Hemophilia Gene Therapy Business (2016-2021) & (US$ Million)

    Table 90. BioMarin Recent Development

    Table 91. uniQure Company Details

    Table 92. uniQure Business Overview

    Table 93. uniQure Hemophilia Gene Therapy Product

    Table 94. uniQure Revenue in Hemophilia Gene Therapy Business (2016-2021) & (US$ Million)

    Table 95. uniQure Recent Development

    Table 96. Freeline Therapeutics Company Details

    Table 97. Freeline Therapeutics Business Overview

    Table 98. Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2016-2021) & (US$ Million)

    Table 99. Freeline Therapeutics Recent Development

    Table 100. Research Programs/Design for This Report

    Table 101. Key Data Information from Secondary Sources

    Table 102. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Hemophilia Gene Therapy Market Share by Type: 2020 VS 2027

    Figure 2. Hemophilia A Features

    Figure 3. Hemophilia B Features

    Figure 4. Global Hemophilia Gene Therapy Market Share by Application: 2020 VS 2027

    Figure 5. Hemophilia A Gene Therapy Case Studies

    Figure 6. Hemophilia B Gene Therapy Case Studies

    Figure 7. Hemophilia Gene Therapy Report Years Considered

    Figure 8. Global Hemophilia Gene Therapy Market Size (US$ Million), Year-over-Year: 2016-2027

    Figure 9. Global Hemophilia Gene Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027

    Figure 10. Global Hemophilia Gene Therapy Market Share by Regions: 2020 VS 2027

    Figure 11. Global Hemophilia Gene Therapy Market Share by Regions (2022-2027)

    Figure 12. Global Hemophilia Gene Therapy Market Share by Players in 2020

    Figure 13. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Gene Therapy as of 2020

    Figure 14. The Top 10 and 5 Players Market Share by Hemophilia Gene Therapy Revenue in 2020

    Figure 15. Global Hemophilia Gene Therapy Revenue Market Share by Type (2016-2021)

    Figure 16. Global Hemophilia Gene Therapy Revenue Market Share by Type (2022-2027)

    Figure 17. North America Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 18. North America Hemophilia Gene Therapy Market Share by Type (2016-2027)

    Figure 19. North America Hemophilia Gene Therapy Market Share by Application (2016-2027)

    Figure 20. North America Hemophilia Gene Therapy Market Share by Country (2016-2027)

    Figure 21. United States Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 22. Canada Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 23. Europe Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 24. Europe Hemophilia Gene Therapy Market Share by Type (2016-2027)

    Figure 25. Europe Hemophilia Gene Therapy Market Share by Application (2016-2027)

    Figure 26. Europe Hemophilia Gene Therapy Market Share by Country (2016-2027)

    Figure 27. Germany Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 28. France Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 29. U.K. Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 30. Italy Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 31. Russia Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 32. Nordic Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 33. Asia-Pacific Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 34. Asia-Pacific Hemophilia Gene Therapy Market Share by Type (2016-2027)

    Figure 35. Asia-Pacific Hemophilia Gene Therapy Market Share by Application (2016-2027)

    Figure 36. Asia-Pacific Hemophilia Gene Therapy Market Share by Region (2016-2027)

    Figure 37. China Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 38. Japan Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 39. South Korea Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 40. Southeast Asia Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 41. India Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 42. Australia Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 43. Latin America Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 44. Latin America Hemophilia Gene Therapy Market Share by Type (2016-2027)

    Figure 45. Latin America Hemophilia Gene Therapy Market Share by Application (2016-2027)

    Figure 46. Latin America Hemophilia Gene Therapy Market Share by Country (2016-2027)

    Figure 47. Mexico Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 48. Brazil Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 49. Middle East & Africa Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 50. Middle East & Africa Hemophilia Gene Therapy Market Share by Type (2016-2027)

    Figure 51. Middle East & Africa Hemophilia Gene Therapy Market Share by Application (2016-2027)

    Figure 52. Middle East & Africa Hemophilia Gene Therapy Market Share by Country (2016-2027)

    Figure 53. Turkey Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 54. Saudi Arabia Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 55. UAE Hemophilia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 56. Spark Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2016-2021)

    Figure 57. Ultragenyx Revenue Growth Rate in Hemophilia Gene Therapy Business (2016-2021)

    Figure 58. Shire PLC Revenue Growth Rate in Hemophilia Gene Therapy Business (2016-2021)

    Figure 59. Sangamo Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2016-2021)

    Figure 60. Bioverativ Revenue Growth Rate in Hemophilia Gene Therapy Business (2016-2021)

    Figure 61. BioMarin Revenue Growth Rate in Hemophilia Gene Therapy Business (2016-2021)

    Figure 62. uniQure Revenue Growth Rate in Hemophilia Gene Therapy Business (2016-2021)

    Figure 63. Freeline Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2016-2021)

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed